Translating Novel Radiopharmaceutical Therapies to Transform the Medical Future

Establish Targeted Radiopharmaceuticals as the Next Pillar of Oncology Drugs Through Innovating Novel Design Approaches, Showcasing Emerging Clinical Data, & Streamlining Isotope Supply & Distribution.

This is the meeting for anyone passionate about bringing the next wave of TRPs to patients. Whether you’re working in discovery, clinical development, manufacturing, or regulation, you’ll find practical insights, open conversations, and solutions you can act on.

For more information and to register, click here.

10-12 November, 2025 | Amsterdam, Netherlands


oncology abstract cell



Share
LinkedIn X Link





News
10 September 2026
Inspiring the next generation: Medicines Discovery Catapult scientist contributes to children’s science book 

Dr Emma Jones, a Lead Scientist in in vitro Neurobiology at Medicines Discovery Catapult (MDC), has contributed to a new children’s book celebrating the diversity of careers in science.


News
03 September 2026
Medicines Discovery Catapult invests in UK biotech pioneers developing novel treatments for chronic diseases

Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.


News
22 July 2026
UK Intracellular Drug Delivery Centre opens for industry access to accelerate next-generation RNA medicines 

The centre will provide integrated expertise and evidence generation to help innovators accelerate the development of next-generation RNA medicines.





Medicines Discovery Catapult